|?|| (C;C) (C;G) (G;G) ||28|
] Fibroblast growth factor 20 polymorphisms and haplotypes strongly influence risk of Parkinson disease.
[PMID 15967032] Lack of evidence for a genetic association between FGF20 and Parkinson's disease in Finnish and Greek patients.
[PMID 18252210] Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by overexpression of alpha-synuclein.
[PMID 19133659] FGF20 and Parkinson's disease: no evidence of association or pathogenicity via alpha-synuclein expression.